Literature DB >> 6852549

Histopathologic changes following carmustine treatment of uveal Greene melanoma in rabbits.

C Ni, L H Liu.   

Abstract

Uveal Greene melanoma was produced in the anterior chamber of 47 eyes in 29 rabbits. One group of rabbits was untreated and served as controls. One group was treated with carmustine (1,3-bis(2-chloroethyl)-1-nitro-sourea; BCNU) intravenously and one group was treated with BCNU both intravenously and locally via an implanted silicone device. Tumor specimens were studied histopathologically with light and electron microscopy. Compared with controls, the treated tumors were smaller, more necrotic, and contained more spindle-shaped cells intermingled with inflammatory cells. Changes were particularly striking in the combined-treatment group. Treated tumors of both groups also showed less invasion into surrounding ocular tissues. Morphologic changes after treatment included the development of numerous degenerative tumor cells with calcium deposition, fragmentation of nuclei, degeneration of mitochondria, accumulation of fat droplets, and disorganization of cytoplasm. These changes may indicate that the drug, particularly following combined delivery, has a cytotoxic effect directly on the tumor cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6852549     DOI: 10.1007/bf02175941

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  11 in total

1.  Enhancement of the antitumor effect of 1,3-bis(2-chloroethyl)-1-nitrosourea by various psychotropic drugs in combination with caffeine.

Authors:  M H Cohen
Journal:  J Pharmacol Exp Ther       Date:  1975-09       Impact factor: 4.030

2.  Quantitative structure-activity relationships in anticancer agents. Activity of selected nitrosoureas against a solid tumor, the Lewis lung carcinoma.

Authors:  J A Montgomery; J G Mayo
Journal:  J Med Chem       Date:  1974-05       Impact factor: 7.446

3.  Experimental intraocular penetration of dacarbazine.

Authors:  Z M Wilczek
Journal:  Am J Ophthalmol       Date:  1977-09       Impact factor: 5.258

4.  Calcifying epithelioma: a clinicopathological analysis of 67 cases with ultrastructural study of 2 cases.

Authors:  C Ni; G P Kimball; J L Craft; W J Wang; C S Chong; D M Albert
Journal:  Int Ophthalmol Clin       Date:  1982

5.  5-Fluorouracil (NSC-19893), DTIC (NSC-45388), BCNU (NSC-409962), and vincristine (NSC-67574) in advanced colorectal carcinoma.

Authors:  F E von Eyben; V Larsen; H Pedersen
Journal:  Cancer Treat Rep       Date:  1976-01

6.  Experimental combined systemic and local chemotherapy for intraocular malignancy.

Authors:  H S Liu; M F Refojo; D M Albert
Journal:  Arch Ophthalmol       Date:  1980-05

Review 7.  Nitrosoureas: a review of experimental antitumor activity.

Authors:  F M Schabel
Journal:  Cancer Treat Rep       Date:  1976-06

Review 8.  1,3-bis(2-chloroethyl)-1-nitrosourea (bcnu) and other nitrosoureas in cancer treatment: a review.

Authors:  S K Carter; F M Schabel; L E Broder; T P Johnston
Journal:  Adv Cancer Res       Date:  1972       Impact factor: 6.242

9.  Sustained release of BCNU for the treatment of intraocular malignancies in animal models.

Authors:  H S Liu; M F Refojo; H D Perry; D M Albert
Journal:  Invest Ophthalmol Vis Sci       Date:  1979-10       Impact factor: 4.799

10.  Tolerance of normal rabbit eyes to the antineoplastic carmustine.

Authors:  H S Liu; H D Perry; M F Refojo
Journal:  Ophthalmologica       Date:  1980       Impact factor: 3.250

View more
  1 in total

1.  Experimental study on the fractionation schedule for proton irradiation of uveal melanoma.

Authors:  G Wollensak; L Zografos; C Perret; E Egger; H Fritz-Niggli
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.